Rheumatology Network

Tech Tips Series #1: Managing the Information Barrage

Our goal at RheumNet is always to help you manage the constant flood of online information for rheumatologists. Here, in the first installment of a new series, Advisory Board member Suleman Bhana MD shares tips for saving, sorting, and retrieving journal articles.

Recent Content

FDA Approves Neupogen Biosimilar, First in US

Lois Wingerson

News | March 06, 2015 | Rheumatic Diseases, Rheumatoid Arthritis

By Lois Wingerson

The filgrastim biosimilar Zarxio, the first approved in the US, can be used to treat patients with acute myelogenous leukemia and bone marrow transplants, among other conditions. A biosimilar form of the rheumatology drug infliximab may be close on its heels.

Why Many RA Patients Close Their Own "Window"

Rita Baron-Faust

News | March 05, 2015 | Rheumatoid Arthritis, Arthritis, Musculoskeletal Citations

By Rita Baron-Faust

There's good reason why it's difficult to "catch" rheumatoid arthritis early enough to assure remission. Patients with early symptoms seek care only when they sense a threat. (Can this be solved?)

New from FDA: Drug Shortages App

Lois Wingerson

News | March 04, 2015 | Rheumatic Diseases

By Lois Wingerson

The FDA has announced a new mobile app that offers updated information about drug shortages.

3 Studies Draw Clear Picture of Lupus Nephritis Outcomes

Rita Baron-Faust

March 04, 2015 | Lupus, Musculoskeletal Citations

By Rita Baron-Faust

Lupus nephritis (LN) flares can arise for 15 years, a newly published longitudinal study shows. Other research reveals predictors of LN outcomes.

Rheumatology Tests and the New Precision Medicine Initiative

Lois Wingerson

News | March 03, 2015 | Rheumatic Diseases, Lupus, Rheumatoid Arthritis

By Lois Wingerson

Rheumatology tests top the list of FDA-approved biomarker panels today. But the most prominent of these has fallen from favor, and rheumatology doesn't even rate a mention in the Precision Medicine Initiative.

How Risky Conversations Fail for Rheumatologists

Rita Baron-Faust

March 02, 2015 | Rheumatoid Arthritis, Musculoskeletal Citations, Rheumatic Diseases

By Rita Baron-Faust

When it comes to discussing medication risks, a new study shows, rheumatologists and their patients are speaking different languages. The article reveals how doctors may be sending messages they don't intend.

Hydroxychloroquine Retinopathy: Misunderstood, and Missed

Norman Bauman

March 02, 2015 | Lupus, Musculoskeletal Citations, Rheumatoid Arthritis

By Norman Bauman

About half of patients taking hydroxychloroquine, which is used for lupus and rheuamtoid arthritis, aren't tested in time for its blinding effects on the retina, says a review. There are simple ways to use the drug safely.

Videos
Slideshows

Sifalimumab and the Struggle to Solve Lupus
Munther Khamashta MD FRCP
January 13, 2015
By Munther Khamashta MD FRCP
(ACR 2014) A drug with a novel mechanism, sifalimumab, shows promise against lupus. In a video interview, Munther Khamastha MD describes the latest research into what could become a second new option for lupus patients.
Sounding Out Arthritis #6: Synovitis
Paul DeMarco MD
December 19, 2014 | Imaging In Rheumatology, Arthritis, Juvenile Arthritis, Rheumatic Diseases
By Paul DeMarco MD
Positioning of the probe is "three-quarters of the battle" in diagnosing synovitis of the wrist or hand, says Dr. DeMarco in this video. But gel technique and pressure are crucial to gaining accurate clinical information from ultrasound imaging of this condition.
Winning Buy-In On a Biosimilar
Michael Wyand PhD DVM
December 18, 2014 | ACR 2014, Rheumatic Diseases, Rheumatoid Arthritis
By Michael Wyand PhD DVM
(ACR14) (VIDEO) In tests so far, the infliximab biosimilar BOW015, just approved in India, seems to look about the same to the human immune system as the original. Here, a VP of the company behind BOW015 talks about the realities of seeking approval in the US.
What Causes the Lasting Insult in Knee OA?
Tuhina Neogi MD
December 05, 2014 | ACR 2014, Arthritis, Osteoarthritis, Rheumatologic Pain
By Tuhina Neogi MD
(ACR2014) (VIDEO) In patients with knee osteoarthritis, which contributes more to the risk of central sensitization of pain: inflammation or injury? Dr. Tuhina Neogi reveals the answer in this video interview.

Interleukin Inhibitors in Brief
February 25, 2015 | Psoriatic Arthritis, Arthritis, Spondyloarthritis
Agents that target the TH17-interleukin pathway show promise in psoriatic arthritis, as alternatives for patients who don't benefit from TNFα blockers. This slide show describes their mode of action and potential.
Rheumatology Journal Club Debut: The Twitter Conversation Condensed
Lois Wingerson
February 03, 2015 | Lupus
By Lois Wingerson
Even if you missed participating in the first-ever rheumatology journal club on Twitter last week at #rheumjc, you can relive the conversation, condensed and edited, in fewer than a dozen slides.
Young Woman With Foot Pain
Eric Bogner MD
January 28, 2015 | Rheumatologic Pain, Rheumatic Diseases
By Eric Bogner MD
A 35-year-old woman presented with pain in her left foot. Although Morton's neuroma might seem the logical cause, there is a different (and unusual) explanation in this case.
Dermatomyositis, DVT, and D-Dimer
Norman Bauman
January 22, 2015 | Myositis
By Norman Bauman
Pulmonary embolism and deep vein thrombosis developed in a 40-year-old man with amyopathic dermatomyositis. D-dimer levels were a red flag.